Exhibit 99.1
March 7, 2024
Alberta Securities Commission |
British Columbia Securities Commission |
Ontario Securities Commission |
RE: Xenon Pharmaceuticals Inc.
Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:
Date of meeting: | June 4, 2024 |
Record date for notice: | April 5, 2024 |
Record date for voting: | April 5, 2024 |
Beneficial ownership determination date: | April 5, 2024 |
Securities entitled to notice: | Common Shares |
Securities entitled to vote: | Common Shares |
Issuer mailing directly to non-objecting beneficial owners: | No |
Issuer will pay for objecting beneficial owner material distribution: | Yes |
Issuer using notice-and-access for registered investors: | No |
Issuer using notice-and-access for non-registered investors: | No |
Notice-and-access stratification criteria: | N/A |
Thank you,
/s/ Tamara Cajuste
Tamara Cajuste
Senior Relationship Manager
Equiniti Trust Company, LLC.
Tel: 347-939-9659
Email: Tamara.Cajuste@equiniti.com